|
Market Closed -
London S.E.
09:05:28 18/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.1750 GBX | 0.00% |
|
0.00% | - |
| 28/08 | WINNERS & LOSERS: McBride rises on deal win; Watkin Jones slumps | AN |
| 29/05 | WINNERS & LOSERS: CelLBxHealth jumps on AstraZeneca partnership | AN |
| Market Cap | 41.8L 55.9L 48.75L 46.03L 78.31L 54Cr 78.64L 5.51Cr 2.13Cr 27Cr 2.1Cr 2.05Cr 88Cr | P/E 2024 * |
-
| P/E 2025 | -2.94x |
|---|---|---|---|---|---|
| Enterprise Value | 73.74L 98.63L 86.01L 81.21L 1.38Cr 95Cr 1.39Cr 9.73Cr 3.75Cr 48Cr 3.71Cr 3.62Cr 154.82Cr | EV / Sales 2024 * |
-
| EV / Sales 2025 | 6,07,961x |
| Free-Float |
68.86% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | 0.18 |  | 0.18 |
| 1 month | 0.1 | | 0.19 |
| Current year | 0.1 | | 0.19 |
| 1 year | 0.1 | | 0.19 |
| 3 years | 0.1 | | 0.35 |
| 5 years | 0.1 | | 1 |
| 10 years | 0.1 | | 4.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 22/12/2025 | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Booth
CHM | Chairman | 60 | 01/01/2022 |
Rumit Shah
BRD | Director/Board Member | - | 30/09/2022 |
| Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/10/23 | Buy | Director | 50,000 | 0.0347% | ||
| 25/11/22 | Buy | Director | 20,000 | 0.0008% | ||
| 25/11/22 | Buy | Director | 50,000 | 0.0021% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | 0.00% | -50.00% | 55.81L | |
| 0.00% | +0.45% | +40.80% | +88.97% | 13TCr | |
| -0.92% | +0.56% | +46.60% | +83.50% | 2.38TCr | |
| -0.61% | +1.36% | +20.20% | +40.82% | 1.71TCr | |
| -1.02% | +0.52% | +18.59% | +26.16% | 1.49TCr | |
| +0.40% | -1.17% | +3.93% | +131.57% | 1.47TCr | |
| -0.91% | +0.39% | -11.47% | +5.61% | 1.35TCr | |
| +1.71% | -4.24% | +82.96% | +81.69% | 1.29TCr | |
| +2.31% | +1.44% | -16.23% | +55.97% | 1.28TCr | |
| +1.71% | +2.57% | +14.36% | +32.90% | 1.2TCr | |
| Average | +0.27% | -0.21% | +19.97% | +49.72% | 2.48TCr | |
| Weighted average by Cap. | +0.07% | +0.15% | +31.53% | +74.53% |
| 2023 | 2024 * | |
|---|---|---|
| Net sales | 5.57 7.45 6.5 6.14 10.44 715.21 10.48 73.51 28.37 363.62 28 27.38 1.17T | - |
| Net income | -2L -3L -2L -2L -4L -2.41Cr -4L -24.73L -10L -1.22Cr -9L -9L -3.94Cr | - |
| Net Debt | 25.71L 34.39L 29.99L 28.32L 48.18L 33Cr 48.38L 3.39Cr 1.31Cr 17Cr 1.29Cr 1.26Cr 54Cr | - |
Employees
-
Sector
Investment Holding Companies
| Date | Price | Change |
|---|---|---|
| 18/26/18 | GBX 0.1750 | 0.00% |
| 17/26/17 | GBX 0.1750 | 0.00% |
| 16/26/16 | GBX 0.1750 | 0.00% |
| 15/26/15 | GBX 0.1750 | 0.00% |
| 14/26/14 | GBX 0.1750 | 0.00% |
- Stock Market
- Stocks
- VOX Stock
Select your edition
All financial news and data tailored to specific country editions
